These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23935247)

  • 41. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis.
    Chiu CH; McEntee MF; Whelan J
    Cancer Res; 1997 Oct; 57(19):4267-73. PubMed ID: 9331087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recovery from 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced immunosuppression in A/J mice by treatment with nonsteroidal anti-inflammatory drugs.
    Rioux N; Castonguay A
    J Natl Cancer Inst; 1997 Jun; 89(12):874-80. PubMed ID: 9196254
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sulindac and its derivatives: a novel class of anticancer agents.
    Haanen C
    Curr Opin Investig Drugs; 2001 May; 2(5):677-83. PubMed ID: 11569947
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Celastrus orbiculatus extract inhibits tumor angiogenesis by targeting vascular endothelial growth factor signaling pathway and shows potent antitumor activity in hepatocarcinomas in Vitro and in Vivo.
    Qian YY; Zhang H; Hou Y; Yuan L; Li GQ; Guo SY; Hisamits T; Liu YQ
    Chin J Integr Med; 2012 Oct; 18(10):752-60. PubMed ID: 21805294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.
    Vistica DT; Hollingshead M; Borgel SD; Kenney S; Stockwin LH; Raffeld M; Schrump DS; Burkett S; Stone G; Butcher DO; Shoemaker RH
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):561-70. PubMed ID: 19636271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades.
    Lee JH; Choi S; Lee Y; Lee HJ; Kim KH; Ahn KS; Bae H; Lee HJ; Lee EO; Ahn KS; Ryu SY; Lü J; Kim SH
    Mol Cancer Ther; 2010 Feb; 9(2):389-99. PubMed ID: 20103598
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sulindac compounds facilitate the cytotoxicity of β-lapachone by up-regulation of NAD(P)H quinone oxidoreductase in human lung cancer cells.
    Kung HN; Weng TY; Liu YL; Lu KS; Chau YP
    PLoS One; 2014; 9(2):e88122. PubMed ID: 24505400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of apoptosis by sulindac sulfide in HL60 cells is enhanced by p21CiP1 or p27KiP1.
    Ikui AE; Yao Y; Zhou P; Weinstein IB
    Anticancer Res; 2001; 21(4A):2297-303. PubMed ID: 11724286
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antitumor effects of sulindac in ovarian cell cultures].
    Jakubowska-Mućka A; Sieńko J; Switaj T; Gołab J; Lasek W
    Ginekol Pol; 2011 Mar; 82(3):195-9. PubMed ID: 21735687
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-cancer effects of COX-2 inhibitors and their correlation with angiogenesis and invasion in gastric cancer.
    Fu SL; Wu YL; Zhang YP; Qiao MM; Chen Y
    World J Gastroenterol; 2004 Jul; 10(13):1971-4. PubMed ID: 15222049
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulindac enhances cell proliferation in DMH-treated mouse colonic mucosa.
    Moorghen M; Orde M; Finney KJ; Appleton DR; Watson AJ
    Cell Prolif; 1998 Apr; 31(2):59-70. PubMed ID: 9745616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sulindac-derived RXRα modulators inhibit cancer cell growth by binding to a novel site.
    Chen L; Wang ZG; Aleshin AE; Chen F; Chen J; Jiang F; Alitongbieke G; Zeng Z; Ma Y; Huang M; Zhou H; Cadwell G; Zheng JF; Huang PQ; Liddington RC; Zhang XK; Su Y
    Chem Biol; 2014 May; 21(5):596-607. PubMed ID: 24704507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting angiogenesis with integrative cancer therapies.
    Yance DR; Sagar SM
    Integr Cancer Ther; 2006 Mar; 5(1):9-29. PubMed ID: 16484711
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined treatment with vitamin C and sulindac synergistically induces p53- and ROS-dependent apoptosis in human colon cancer cells.
    Gong EY; Shin YJ; Hwang IY; Kim JH; Kim SM; Moon JH; Shin JS; Lee DH; Hur DY; Jin DH; Hong SW; Lee WK; Lee WJ
    Toxicol Lett; 2016 Sep; 258():126-133. PubMed ID: 27339904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells.
    He Q; Luo X; Huang Y; Sheikh MS
    Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of anti-inflammatory and antimicrobial herbal remedy PADMA 28 on immunological angiogenesis and granulocytes activity in mice.
    Radomska-Leśniewska DM; Skopiński P; Niemcewicz M; Zdanowski R; Lewicki S; Kocik J; Skopińska-Różewska E; Stankiewicz W
    Mediators Inflamm; 2013; 2013():853475. PubMed ID: 23864768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice.
    Bi X; Pohl N; Dong H; Yang W
    J Hematol Oncol; 2013 Jan; 6():8. PubMed ID: 23327547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of chemically induced skin carcinogenesis by sulindac is independent of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta).
    Kim DJ; Prabhu KS; Gonzalez FJ; Peters JM
    Carcinogenesis; 2006 May; 27(5):1105-12. PubMed ID: 16418176
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The conventional nonsteroidal anti-inflammatory drug sulindac sulfide arrests ovarian cancer cell growth via the expression of NAG-1/MIC-1/GDF-15.
    Kim JS; Baek SJ; Sali T; Eling TE
    Mol Cancer Ther; 2005 Mar; 4(3):487-93. PubMed ID: 15767558
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PDE5 and PDE10 inhibition activates cGMP/PKG signaling to block Wnt/β-catenin transcription, cancer cell growth, and tumor immunity.
    Piazza GA; Ward A; Chen X; Maxuitenko Y; Coley A; Aboelella NS; Buchsbaum DJ; Boyd MR; Keeton AB; Zhou G
    Drug Discov Today; 2020 Aug; 25(8):1521-1527. PubMed ID: 32562844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.